CNC Looks 16.2% Undervalued on GF Value™ Despite Unprofitability
Centene Corporation (CNC) rose 3.25% on September 10, 2026, with a 55.67% year-to-date return. Its P/S ratio is 0.16, below historical and industry averages, suggesting undervaluation. The GF Value™ indicates a 16.2% undervaluation, but earnings are negative. Insider activity shows $14.6M in sales, while gurus have mixed sentiment.
How this was made
The 30-second read
Why it matters
The article provides a fresh valuation angle (GF Value) that could drive short‑term buying, but the company’s negative earnings remain a downside risk.
Market read
A modest price surge driven by valuation metrics may influence other loss‑making health insurers.
What to watch
Cash‑flow constraints and margin compression could outweigh the low P/S appeal.
Background
Centene is a large managed‑care insurer with a market cap of $32.7 B, serving ~20 M members across Medicaid, Medicare, and individual exchanges.
Ticker impact
Centene (CNC) rose 3.25% on Sep 10, 2026, after the article highlighted its 0.16 P/S ratio and a GF Value indicating ~16% undervaluation.
Short‑term upside likely to continue if valuation narrative holds; risk remains from negative earnings.
A low P/S and GF Value signal are new data points that can attract short‑term buying, but the company’s unprofitability limits upside.
Market effects
The move may prompt a broader re‑rating of managed‑care stocks with low P/S multiples.
U.S. healthcare sector could see modest buying pressure.
Limited; primarily a U.S. equity story.
Counterpoint
The valuation discount may be justified by persistent losses; the rally could be speculative and unsustainable.
Key entities
- companyCentene Corporation
U.S. managed‑care insurer (ticker CNC).
